Insights
Benchmark International Successfully Facilitated the Transaction Between Metaphase Design Group, Inc. and Aptar Pharma
September 15, 2022
Metaphase Design Group, Inc. is a leader in applying the science of human factors engineering and ergonomics to product design. Metaphase incorporates various areas of specialization in their User-Centered Design Innovation Process, combining them with extensive expertise in Industrial Design and Human Factors research and support.
Aptar Pharma is a global leader in drug delivery and active material science solutions and services. Post-acquisition, Metaphase will be integrated into Noble, an Aptar Pharma company and a world leader in drug delivery training device programs, medical device training solutions, market insight services and patient onboarding strategies. The addition of Metaphase to Noble enhances Aptar Pharma’s patient-centric approach. Metaphase’s expertise will also complement the products and services that Noble currently provides to pharmaceutical and biotech companies to help improve patient training and onboarding, including their Human Factors Plus (HF+) program.
“We are excited to be joining Aptar Pharma and expanding our ability to impact the pharmaceutical industry and help our clients optimize the design of their devices while continuing to serve our loyal client base in healthcare, consumer, and food and beverage markets,” stated Dr. Bryce Rutter, Metaphase Design Group CEO. “Combining our resources with the foundation that Noble has established with their Human Factors Plus program will also better enable us to represent the voice of the user throughout the product development journey.”
“When Benchmark International reached out to me, they were the only M&A firm of many who had done a deep dive on my company and truly understood our strategic value prior to the first call. Benchmark was an invaluable asset in posturing my company’s strategic value for sale. Their responsiveness and thoughtful guidance led to a terrific outcome for me selling Metaphase. Beyond the transaction itself, every person I dealt with at Benchmark International was an A-team player and as a company, demonstrated exemplar integrity. I could not have envisioned a better M&A partner. Thanks Benchmark International!” - Bryce G. Rutter, Founder & CEO of Metaphase Design Group Inc.
“Dr. Bryce Rutter and his team were exceptional clients to work with throughout this process. From the initial conversation on potential strategic fit, through to closing, both Metaphase and the Aptar Team worked tirelessly to see this transaction close. I cannot thank Isabelle Menard and her team enough at Aptar Pharma for ensuring this would be a successful partnership within their Noble Division. From the very beginning, Aptar dedicated their full focus to ensure this new partnership would be a win for both groups.” – Jack Chilcutt, Senior Deal Analyst.
Share This Post
Categories
Get These Insights Delivered Directly To Your Email
Explore our curated collection today and stay ahead of the curve in M&A.
Related Posts
Benchmark International Rolls Out New Interactive Publication of the MarkBenchmark International has released a new publication, The Mark, which is an award-winning publication that offers exclusive insights into the world of mergers and acquisitions and specialized guidance for business owners on a wide range of important topics.Kendall Stafford Recognized as Investment Banker of the Year and Benchmark International Earns Cross Border Deal of the Year at M&A Advisor AwardsAt the 23rd Annual M&A Advisor Awards, Kendall Stafford, Managing Partner at Benchmark International, was named Investment Banker of the Year.